218 related articles for article (PubMed ID: 12694386)
1. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats.
Meissner W; Harnack D; Reese R; Paul G; Reum T; Ansorge M; Kusserow H; Winter C; Morgenstern R; Kupsch A
J Neurochem; 2003 May; 85(3):601-9. PubMed ID: 12694386
[TBL] [Abstract][Full Text] [Related]
2. High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats.
Bruet N; Windels F; Bertrand A; Feuerstein C; Poupard A; Savasta M
J Neuropathol Exp Neurol; 2001 Jan; 60(1):15-24. PubMed ID: 11202172
[TBL] [Abstract][Full Text] [Related]
3. High frequency stimulation of the entopeduncular nucleus has no effect on striatal dopaminergic transmission.
Meissner W; Harnack D; Hoessle N; Bezard E; Winter C; Morgenstern R; Kupsch A
Neurochem Int; 2004 Mar; 44(4):281-6. PubMed ID: 14602091
[TBL] [Abstract][Full Text] [Related]
4. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
[TBL] [Abstract][Full Text] [Related]
5. Dopamine efflux in the rat striatum evoked by electrical stimulation of the subthalamic nucleus: potential mechanism of action in Parkinson's disease.
Lee KH; Blaha CD; Harris BT; Cooper S; Hitti FL; Leiter JC; Roberts DW; Kim U
Eur J Neurosci; 2006 Feb; 23(4):1005-14. PubMed ID: 16519665
[TBL] [Abstract][Full Text] [Related]
6. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine.
Rodríguez-Gómez JA; Romero-Ramos M; Vizuete ML; Venero JL; Cano J; Machado A
Mol Pharmacol; 1997 Oct; 52(4):641-7. PubMed ID: 9380027
[TBL] [Abstract][Full Text] [Related]
7. High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat.
Paul G; Reum T; Meissner W; Marburger A; Sohr R; Morgenstern R; Kupsch A
Neuroreport; 2000 Feb; 11(3):441-4. PubMed ID: 10718291
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
[TBL] [Abstract][Full Text] [Related]
9. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.
Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S
Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727
[TBL] [Abstract][Full Text] [Related]
10. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
[TBL] [Abstract][Full Text] [Related]
11. Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats.
Meissner W; Harnack D; Paul G; Reum T; Sohr R; Morgenstern R; Kupsch A
Neurosci Lett; 2002 Aug; 328(2):105-8. PubMed ID: 12133566
[TBL] [Abstract][Full Text] [Related]
12. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
Robertson GS; Damsma G; Fibiger HC
J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
[TBL] [Abstract][Full Text] [Related]
13. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
[TBL] [Abstract][Full Text] [Related]
14. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
Gołembiowska K; Dziubina A
Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
[TBL] [Abstract][Full Text] [Related]
15. Reserpine-insensitive dopamine release in the substantia nigra?
Elverfors A; Nissbrandt H
Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic relationship between dopamine and iron in the striatal dopaminergic nerve terminals.
Santiago M; Matarredona ER; Granero L; Cano J; Machado A
Brain Res; 2000 Mar; 858(1):26-32. PubMed ID: 10700592
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
Andrés ME; Gysling K; Bustos G
Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
[TBL] [Abstract][Full Text] [Related]
18. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
[TBL] [Abstract][Full Text] [Related]
19. Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine.
Pazo JH; Höcht C; Barceló AC; Fillipini B; Lomastro MJ
Synapse; 2010 Dec; 64(12):905-15. PubMed ID: 20939061
[TBL] [Abstract][Full Text] [Related]
20. Does monoamine oxidase inhibition by pargyline increase extracellular dopamine concentrations in the striatum?
Blaha CD; Coury A; Phillips AG
Neuroscience; 1996 Nov; 75(2):543-50. PubMed ID: 8931017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
